Screener
Perspective Therapeutics CATX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Perspective Therapeutics’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:34 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342512
FAQ
- What is Perspective Therapeutics's EPS (diluted)?
- Perspective Therapeutics (CATX) reported EPS (diluted) of -$0.22 in Q2 2026.
- How has Perspective Therapeutics's EPS (diluted) changed year-over-year?
- Perspective Therapeutics's EPS (diluted) increased by 24.1% year-over-year, from -$0.29 to -$0.22.
- What is the long-term trend for Perspective Therapeutics's EPS (diluted)?
- Over 3 years (2021 to 2025), Perspective Therapeutics's EPS (diluted) has grown at a 203.7% compound annual growth rate (CAGR), from -$0.05 to -$1.40.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Perspective Therapeutics's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude